Kim Se Il, Choi YongMin
Department of Rehabilitation Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Republic of Korea.
Department of Rehabilitation Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Republic of Korea.
J Pain Symptom Manage. 2022 Apr;63(4):e441-e444. doi: 10.1016/j.jpainsymman.2021.11.014. Epub 2021 Dec 8.
Muscle invasion (MI) in patients with far-advanced cancer is often accompanied with pain. Conventional treatments used for pain relief may be associated with several side effects. We describe two cases of botulinum toxin injection (BTI) for relieving intractable pain in patients of far-advanced cancer having MI. The patients presented with persistent intractable pain that did not respond to conventional treatments, such as analgesic medications, epidural steroid injection, and radiotherapy. BTI relieved the intractable pain in these cases for at least 9-12 weeks without any reported side effects. We suggest that BTI can be an alternative method to relieve intractable pain associated with MI in patients with far-advanced cancer.
晚期癌症患者出现肌肉浸润(MI)时常常伴有疼痛。用于缓解疼痛的传统治疗方法可能会有多种副作用。我们描述了两例肉毒杆菌毒素注射(BTI)用于缓解晚期癌症伴MI患者顽固性疼痛的病例。这些患者表现为持续性顽固性疼痛,对诸如镇痛药、硬膜外类固醇注射及放疗等传统治疗均无反应。BTI在这些病例中缓解了顽固性疼痛,持续至少9至12周,且未报告任何副作用。我们认为BTI可以作为缓解晚期癌症患者与MI相关顽固性疼痛的一种替代方法。